Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clarivate (CLVT) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Clarivate (CLVT) over the last 9 years, with Q3 2025 value amounting to $318.7 million.

  • Clarivate's Cash & Equivalents fell 1796.65% to $318.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $318.7 million, marking a year-over-year decrease of 1796.65%. This contributed to the annual value of $295.2 million for FY2024, which is 2036.69% down from last year.
  • Latest data reveals that Clarivate reported Cash & Equivalents of $318.7 million as of Q3 2025, which was down 1796.65% from $362.6 million recorded in Q2 2025.
  • Clarivate's 5-year Cash & Equivalents high stood at $2.6 billion for Q2 2021, and its period low was $295.2 million during Q4 2024.
  • Moreover, its 5-year median value for Cash & Equivalents was $376.4 million (2024), whereas its average is $608.4 million.
  • As far as peak fluctuations go, Clarivate's Cash & Equivalents soared by 32062.57% in 2021, and later plummeted by 8594.7% in 2022.
  • Over the past 5 years, Clarivate's Cash & Equivalents (Quarter) stood at $430.9 million in 2021, then decreased by 17.2% to $356.8 million in 2022, then grew by 3.9% to $370.7 million in 2023, then dropped by 20.37% to $295.2 million in 2024, then grew by 7.96% to $318.7 million in 2025.
  • Its Cash & Equivalents stands at $318.7 million for Q3 2025, versus $362.6 million for Q2 2025 and $354.0 million for Q1 2025.